Skip to content

Granza Bio

YC W24 · Active · Building programmable therapeutics for the immune system

Competitors

Adjacent

Also from W24

All of W24

About Granza Bio

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

YC batch
W24 · Winter 2024
Status, per YC
Active
Category
Other
Team size
8
Location
San Francisco, CA, USA
Checked
34m ago

YC tags: Synthetic Biology, Biotech, Healthcare, Therapeutics, Oncology

Granza Bio in W24: 248 companies, 83% AI

Granza Bio: questions

Which YC batch was Granza Bio in?

Granza Bio was in Y Combinator's Winter 2024 batch (W24).

Is Granza Bio still active?

Y Combinator lists Granza Bio as active.

Where is Granza Bio based?

Granza Bio lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.